Outlook Therapeutics, Inc. (OTLK)

NASDAQ: OTLK · IEX Real-Time Price · USD

8.09

-0.08 (-0.98%)

At close: Apr 22, 2024, 4:00 PM

8.38

+0.29 (3.58%)

After-hours: Apr 22, 2024, 7:35 PM EDT

Outlook Therapeutics Income Statement

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue	0	0	0	0	8.15	3.09	3.81	2.98	5.22	9.05
Revenue Growth (YoY)	-	-	-	-	163.84%	-18.99%	27.92%	-42.91%	-42.33%	-
Gross Profit	0	0	0	0	8.15	3.09	3.81	2.98	5.22	9.05
Selling, General & Admin	26.67	20.74	12.77	9.97	9.37	14.23	15.88	21.56	12.91	7.32
Research & Development	26.45	42.33	38.96	26.34	23.81	18.5	23.81	32.76	38.88	14.12
Other Operating Expenses	0	0	0	0.53	11.27	0	0	0	0	0
Operating Expenses	53.13	63.07	51.73	36.84	44.45	32.73	39.69	54.33	51.78	21.44
Operating Income	-53.13	-63.07	-51.73	-36.84	-36.3	-29.64	-35.88	-51.35	-46.56	-12.39
Interest Expense / Income	1.56	1.49	0.94	1.76	3.47	3.89	5.63	1.85	2.3	0.9
Other Expense / Income	4.29	1.49	0.5	-0.09	-1.83	0.2	-3.16	-	-1.28	-
Pretax Income	-58.98	-66.05	-53.16	-38.51	-37.93	-33.74	-38.35	-53.2	-47.58	-13.29
Income Tax	0	0	0	-3.27	-3.41	-3.65	0.5	0.1	-0.19	0.44
Net Income	-58.98	-66.05	-53.16	-35.24	-34.52	-30.09	-38.85	-53.3	-47.39	-13.73
Preferred Dividends	0	0	0	13.63	1.52	17.93	1.18	9.84	5.61	6.93
Net Income Common	-58.98	-66.05	-53.16	-48.87	-36.04	-48.02	-40.03	-63.14	-53	-20.66
Shares Outstanding (Basic)	13	11	8	4	1	0	0	0	0	0
Shares Outstanding (Diluted)	13	11	8	4	1	0	0	0	0	0
Shares Change	17.96%	38.91%	110.43%	298.84%	268.84%	64.12%	39.67%	76.48%	14.62%	-
EPS (Basic)	-4.80	-6.20	-7.00	-13.40	-39.60	-194.80	-267.20	-587.20	-868.80	-388.80
EPS (Diluted)	-4.80	-6.20	-7.00	-13.40	-39.60	-194.80	-288.00	-587.20	-868.80	-388.80
Free Cash Flow	-42.97	-56.67	-54.25	-31.79	-32.73	-35.82	-15.8	-46.58	-36.28	-9.39
Free Cash Flow Per Share	-3.44	-5.34	-7.11	-8.76	-35.98	-145.25	-105.22	-432.98	-595.15	-176.50
Gross Margin	-	-	-	-	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Operating Margin	-	-	-	-	-445.60%	-960.12%	-941.36%	-1723.30%	-892.13%	-136.92%
Profit Margin	-	-	-	-	-442.41%	-1555.24%	-1050.13%	-2119.06%	-1015.44%	-228.26%
Free Cash Flow Margin	-	-	-	-	-401.75%	-1160.16%	-414.46%	-1563.34%	-695.13%	-103.72%
EBITDA	-57.38	-64.36	-51.96	-36.2	-31.11	-26.79	-30.03	-48.95	-43.46	-11.51
EBITDA Margin	-	-	-	-	-381.85%	-867.82%	-787.87%	-1642.95%	-832.72%	-127.22%
Depreciation & Amortization	0.04	0.2	0.26	0.55	3.36	3.05	2.69	2.39	1.82	0.88
EBIT	-57.42	-64.56	-52.23	-36.75	-34.47	-29.85	-32.72	-51.35	-45.29	-12.39
EBIT Margin	-	-	-	-	-423.12%	-966.75%	-858.50%	-1723.30%	-867.68%	-136.92%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).